Meridian Clinical Research

Savannah, Georgia 31406

0 studies enrolling now · 47 studies all time

What they study most

Acne Vulgaris, Age Related Osteoporosis, Anxiety, Atopic Dermatitis, COVID-19, Clostridium Difficile Associated Disease, Clostridium Difficile Infection, Cytomegalovirus, Depression, Dermatitis, Atopic, Epilepsy, Episodic Migraine

Studies at this site

• Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults — Completed
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed
• A Study of Modified mRNA Vaccines in Healthy Adults — Completed
• Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Completed
• To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. — Completed
• Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI) — Running, not enrolling
• Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension — Completed
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) — Completed
• Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants — Completed
• Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults — Completed
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
• Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults — Completed
• A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 — Completed
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension — Completed
• A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine — Completed
• Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents — Completed
• Acute Treatment Trial in Adult Subjects With Migraines — Completed
• Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• Safety and Efficacy Study in Adult Subjects With Acute Migraines — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older — Completed
• A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip — Completed
• A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis — Completed
• Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer — Stopped early
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults — Running, not enrolling
• A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults — Completed
• Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine — Stopped early
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed
• RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults — Completed
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris — Completed
• Genomics Used to Improve DEpression Decisions — Completed
• Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse — Completed
• Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris — Completed
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine — Completed
• Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects — Completed
• Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy — Completed
• Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older — Completed
• A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine. — Completed
• Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety — Completed
• Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age — Completed
• Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer — Completed
• In Vitro Diagnostic Device for the Detection of Strep A — Completed
• Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults. — Completed
• Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age — Completed